Literature DB >> 16314845

Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells.

D Mangoura1, Y Sun, C Li, D Singh, D H Gutmann, A Flores, M Ahmed, G Vallianatos.   

Abstract

Children with neurofibromatosis (NF1) typically develop central nervous system (CNS) abnormalities, including aberrant proliferation of astrocytes and formation of benign astrocytomas. The NF1 gene encodes neurofibromin, a Ras-GAP, highly expressed in developing neural cells; the mechanism of regulation of neurofibromin as a Ras-GAP, remains however unknown. We now show that, in response to EGF, neurofibromin is in vivo phosphorylated on serine residues by PKC-alpha, in human, rat, and avian CNS cells and cell lines. EGF-induced PKC phosphorylation was prominent in the cysteine/serine-rich domain (CSRD) of neurofibromin, which lies in the N-terminus and upstream of the Ras-GAP domain (GRD), and this modification significantly increased the association of neurofibromin with actin in co-immunoprecipitations. In addition, we show that Ras activation in response to EGF was significantly lowered when C62B cells overexpressed a construct encoding both CSRD + GRD. Moreover, when PKC-alpha was downregulated, the Ras-GAP activity of CSRD + GRD was significantly diminished, whereas overexpressed GRD alone acted as a weaker GAP and in a PKC-independent manner. Most importantly, functional Ras inhibition and EGF signaling shifts were established at the single cell level in C6-derived cell lines stably overexpressing CSRD + GRD, when transient co-overexpression of Ras and PKC-depletion prior to stimulation with EGF-induced mitosis. Taken together, these data provide the first evidence of a functional, allosteric regulation of GRD by CSRD, which requires neurofibromin phosphorylation by PKC and association with the actin cytoskeleton. Our data may suggest a novel mechanism for regulating biological responses to EGF and provide a new aspect for the understanding of the aberrant proliferation seen in the CNS of children with NF1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16314845     DOI: 10.1038/sj.onc.1209113

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

Review 2.  Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and Interactions.

Authors:  Klaus Scheffzek; Giridhar Shivalingaiah
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

3.  Increased wild-type N-ras activation by neurofibromin down-regulation increases human neuroblastoma stem cell malignancy.

Authors:  Dan Han; Barbara A Spengler; Robert A Ross
Journal:  Genes Cancer       Date:  2011-11

Review 4.  Alternative splicing of the neurofibromatosis type I pre-mRNA.

Authors:  Victoria A Barron; Hua Lou
Journal:  Biosci Rep       Date:  2012-04-01       Impact factor: 3.840

Review 5.  Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.

Authors:  Nicole M Brossier; Steven L Carroll
Journal:  Brain Res Bull       Date:  2011-08-10       Impact factor: 4.077

Review 6.  The pathoetiology of neurofibromatosis 1.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Anthony M Heape; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

7.  Differential Regulation of RasGAPs in Cancer.

Authors:  Thomas Grewal; Meryem Koese; Francesc Tebar; Carlos Enrich
Journal:  Genes Cancer       Date:  2011-03

8.  A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.

Authors:  Irma B Stowe; Ellen L Mercado; Timothy R Stowe; Erika L Bell; Juan A Oses-Prieto; Hilda Hernández; Alma L Burlingame; Frank McCormick
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

9.  Down-regulated Six2 by knockdown of neurofibromin results in apoptosis of metanephric mesenchyme cells in vitro.

Authors:  Puhui Zhou; Tielin Chen; Yin Fang; Honglian Wang; Mi Li; Pengpeng Ma; Lu He; Qianyin Li; Tianming Liu; Xianggui Yang; Fang Nie; Xiaoyan Wang; Yue Yuan; Li Zhou; Rui Peng; Zhicheng Liu; Qin Zhou
Journal:  Mol Cell Biochem       Date:  2014-02-27       Impact factor: 3.396

10.  Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation.

Authors:  Ivan Shun Ho; Frances Hannan; Hui-Fu Guo; Inessa Hakker; Yi Zhong
Journal:  J Neurosci       Date:  2007-06-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.